Daniel Gendron, MD
![Daniel Gendron, MD Daniel Gendron, MD](/neuro/files/neuro/styles/medium_focal__220_x_220_/public/gendron.jpg?itok=pJCJikT2)
Dr. Daniel Gendron and his co-workers provide excellent back-up for clinical diagnosis in the Institute. Dr. Gendron is also active in experimental trials of pyridostigmin treatment protocols for the post-polio syndrome.
Trojan DA, Gendron D, Cashman NR. Stimulation frequency-dependent neuromuscular junction transmission defects in patients with prior poliomyelitis. J Neurol Sci. 1993 Sep;118(2):150-7.
Trojan DA, Gendron D, Cashman NR. Anticholinesterase-responsive neuromuscular junction transmission defects in post-poliomyelitis fatigue. J Neurol Sci. 1993 Feb;114(2):170-7.
Trojan DA, Gendron D, Cashman NR. Electrophysiology and electrodiagnosis of the post-polio motor unit. Orthopedics. 1991 Dec;14(12):1353-61. Review.
Teitelbaum JS, Zatorre RJ, Carpenter S, Gendron D, Evans AC, Gjedde A, Cashman NR. Neurologic sequelae of domoic acid intoxication due to the ingestion of contaminated mussels. N Engl J Med. 1990 Jun 21;322(25):1781-7.
So N, Berkovic S, Andermann F, Kuzniecky R, Gendron D, Quesney LF. Myoclonus epilepsy and ragged-red fibres (MERRF). 2. Electrophysiological studies and comparison with other progressive myoclonus epilepsies. Brain. 1989 Oct;112 ( Pt 5):1261-76.